Skip to NavigationSkip to content

Pharmafile - Medical Communications

Theramex pioneers new treatment for post-menopausal women
Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of Bijuva/...
Eurazeo set to become leading investor in Kurma Partners
Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology and medical...
AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients
The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic...
AstraZeneca and VaxEquity to collaborate on saRNA platform
AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the...
>> More Medical Communications News Stories

Features

Medical cannabis: The next innovation in oncology?

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp of a breakthrough in oncology. Kat...

>> More Features

Appointments

Stelis Biopharma appoints Mark Womack as new CEO

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.

Womack is also the Managing...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches